Increased Cytokeratin 19 Fragment Levels Are Positively Correlated with Adenosine Deaminase Activity in Malignant Pleural Effusions from Adenocarcinomas

Disease Markers
Jorge Luiz BarilloElizabeth Giestal de Araujo

Abstract

Adenosine deaminase (ADA) and cytokeratin 19 (CK19) are known pleural biomarkers. Although ADA in humans functions mainly in the immune system, it also appears to be associated with the differentiation of epithelial cells. Keratin filaments are important structural stabilizers of epithelial cells and potent biomarkers in epithelial differentiation. This study aimed to investigate the simultaneous presence of the ADA enzyme and CK19 fragments to assess epithelial differentiation in malignant and benign pleural fluids. Diagnosis of the cause of pleural effusion syndrome was confirmed by means of standard examinations and appropriate surgical procedures. An ADA assay, in which ADA irreversibly catalyzes the conversion of adenosine into inosine, was performed using a commercial kit. The CK19 assay was performed using a CYFRA 21-1 kit, developed to detect quantitative soluble fragments of CK19 using an electrochemiluminescence immunoassay. One hundred nineteen pleural fluid samples were collected from untreated individuals with pleural effusion syndrome due to several causes. ADA levels only correlated with CK19 fragments in adenocarcinomas, with high significance and good correlation (rho = 0.5145, P = 0.0036). However, further stu...Continue Reading

References

Jan 1, 1985·Annals of the New York Academy of Sciences·M E Balis
Oct 29, 2000·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·M MiédougéG Serre
Mar 5, 2004·International Journal of Clinical Practice·Hasan UstünAhmet Yilmaz
Aug 25, 2007·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Stig Linder
May 8, 2008·Histochemistry and Cell Biology·Roland MollLutz Langbein
Sep 14, 2010·Jornal brasileiro de pneumologia : publicaça̋o oficial da Sociedade Brasileira de Pneumologia e Tisilogia·Bernardo Henrique Ferraz MaranhãoGilberto Perez Cardoso
Sep 21, 2010·Clinical Biochemistry·Hervé DelacourPascal Burnat
Oct 15, 2013·Immunological Reviews·Janis K Burkhardt
Oct 15, 2013·Immunological Reviews·Alex T RitterGillian M Griffiths
Aug 1, 2014·Molecular Cancer Research : MCR·Sanna S VirtanenGennady G Yegutkin
Aug 21, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·William D TravisUNKNOWN WHO Panel
Dec 26, 2015·Advances in Experimental Medicine and Biology·Vivek Mittal
May 26, 2016·Asian Pacific Journal of Cancer Prevention : APJCP·Deepak Chandrakant KelgandreNiharika Swain
Jul 15, 2016·Redox Report : Communications in Free Radical Research·Necip PirinççiKadir Ceylan
Dec 3, 2016·Indian Journal of Dermatology·Avijit Hazra, Nithya Gogtay
Mar 9, 2017·Expert Review of Respiratory Medicine·José M PorcelY C Gary Lee
Apr 21, 2017·Respiration; International Review of Thoracic Diseases·Yuan YangHuan-Zhong Shi

❮ Previous
Next ❯

Methods Mentioned

BETA
deamination
biopsy

Software Mentioned

GraphPad

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.